Experience
Our client had the technology and the IP but not the market presence. A major pharmaceutical company needed a portfolio of diagnostic products. We assisted our client in a lengthy negotiation over a partnership arrangement that allowed both companies to prosper. While IP was an important part of the transaction, we assisted in creating contractual protection of the client’s business interests, particularly in the event of a separation. We have continued to assist the client with amendments and interpretations that reflect a continuing evolution of the relationship and of the market.
Siemens Healthcare Diagnostics Inc. v. Radiometer Medical ApS
Radiometer Medical ApS
Developing a strategic IP portfolio for growing medical device company
BrainScope Company, Inc.
Aerin Medical Inc. et al. v. Neurent Medical Inc. et al.
Aerin Medical Inc. et al.
ACTA Medical L.L.C. v. Curlin Medical Inc.
Moog, Inc.; Curlin Medical Inc.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.